<DOC>
	<DOCNO>NCT01124890</DOCNO>
	<brief_summary>SIAM III multicenter , randomize , prospective , controlled trial patient ST-elevation myocardial infarction receive fibrinolysis &lt; 12 hour onset symptom . All patient receive reteplase , aspirin combination ticlopidin , heparin . Patients early PCI group transfer within 6 hour fibrinolysis PCI . The conservative group receive elective PCI two week fibrinolysis . In total 197 patient include , 163 treat PCI . The primary end point composite ischemic event , death , reinfarction , target lesion revascularization .</brief_summary>
	<brief_title>Southwest German Interventional Study Acute Myocardial Infarction III</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Symptoms MI present 12 h ST segment elevation least 1 mm two limb lead , ST segment elevation least 2 mm precordial lead , new bundlebranch block Patients eligible thrombolysis Informed consent participation Secondary iatrogenic infarction Chronic renal insufficiency require dialysis Coronary anatomy unsuitable stent placement Anticipated indication surgical coronary revascularization within 6 month Previous MI area infarct related vessel Infarct related lesion clearly define</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>acute myocardial infarction</keyword>
	<keyword>thrombolysis</keyword>
	<keyword>percutaneous coronary interention</keyword>
</DOC>